Arama Sonuçları - Prapti Patel

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML Yazar: Pau Montesinos, Dylan M. Marchione, Christian Recher, Michael Heuser, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Marta Riva, Rodrigo T. Calado, Andre C. Schuh, Su-Peng Yeh, Adriana E. Tron, Jianan Hui, Diego A. Gianolio, Sung Choe, Prapti Patel, Stéphane De Botton, Courtney D. DiNardo, Hartmut Döhner

Tam Metin Erişim

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia Yazar: Athalia R. Pyzer, Laura W. Dillon, Elad Sharon, Theodore G. Karrison, Yuanyuan Zha, Noreen Fulton, Gege Gui, Georgia Andrew, Howard Streicher, Kendra Sweet, George Yaghmour, Jane Jijun Liu, Brian A. Jonas, Aaron D. Schimmer, Steven Grant, Amer M. Zeidan, Gerhard C. Hildebrandt, Christopher H. Lowrey, Ryan J. Mattison, Neil Palmisiano, Amandeep Salhotra, Dimitrios Tzachanis, Maria R. Baer, Tara L. Lin, Prapti Patel, Helen Chen, Walter M. Stadler, Olatoyosi Odenike, Richard A. Larson, Thomas F. Gajewski, Christopher S. Hourigan, Wendy Stock, Hongtao Liu

Tam Metin Erişim

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results Yazar: Michael J. Hochman, Amy S. Ruppert, Ying Huang, Alice Mims, Uma Borate, Ronan Swords, Elie Traer, Maria R. Baer, Vu H. Duong, Wendy Stock, Toyosi Odenike, Prapti Patel, Yazan Madanat, Eytan Stein, Michael W. Deininger, Gary Schiller, Daniel A. Pollyea, James M. Foran, Rebecca Olin, Tara Lin, Michael M. Boyiadzis, Shivani Handa, Bjoern Rueter, Theophilus J. Gana, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Amy Burd, Ashley O. Yocum, John C. Byrd, William Blum

Tam Metin Erişim